Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Mindray’s Q1 Underwhelms Investors

publication date: May 12, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Mindray Medical International Limited (迈瑞医疗国际有限公司), the Shenzhen maker of medical devices, announced its Q1 revenues jumped 54% to $134.2 million. Net income, however, failed to keep pace with revenues, rising just 10% higher to $30.5 million on a non-GAAP basis and $25.3 million following GAAP rules. The numbers were a bit of a disappointment as analysts expected the company’s revenues to be close to $145 million, though earnings came in slightly ahead of forecasts. More details..

Stock Symbol: (NYSE: MR)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners